AXIM Biotechnologies, Inc. (OTCMKTS:AXIM – Get Free Report) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 16,547 shares, an increase of ∞ from the April 30th total of 0 shares. Based on an average daily trading volume, of 130,387 shares, the short-interest ratio is currently 0.1 days.
AXIM Biotechnologies Price Performance
OTCMKTS:AXIM opened at $0.01 on Tuesday. The firm has a 50-day moving average of $0.01 and a two-hundred day moving average of $0.01. AXIM Biotechnologies has a 1-year low of $0.00 and a 1-year high of $0.03.
AXIM Biotechnologies Company Profile
AXIM Biotechnologies, Inc is a development-stage biotechnology company focused on the research, development and commercialization of cannabinoid-based technologies. The company’s primary objective is to advance formulations and delivery systems for cannabidiol (CBD) and other cannabinoids, targeting applications in nutraceuticals, skincare and medical devices. Through its proprietary encapsulation and atomization techniques, AXIM aims to enhance the bioavailability and stability of cannabinoid compounds for consumer and clinical use.
The company’s product pipeline includes novel CBD-infused nutraceuticals designed to promote general wellness, as well as specialized formulations for topical and inhalation delivery.
See Also
- Five stocks we like better than AXIM Biotechnologies
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for AXIM Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXIM Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
